Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1969 Nov 22;4(5681):496. doi: 10.1136/bmj.4.5681.496-a

Delayed phenytoin idiosyncrasy.

S Behrman
PMCID: PMC1630508  PMID: 5354845

Full text

PDF

Page 496

496

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hansen J. M., Kristensen M., Skovsted L., Christensen L. K. Dicoumarol-induced diphenylhydantoin intoxication. Lancet. 1966 Jul 30;2(7457):265–266. doi: 10.1016/s0140-6736(66)92547-5. [DOI] [PubMed] [Google Scholar]
  2. KUTT H., WINTERS W., KOKENGE R., MCDOWELL F. DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY. Arch Neurol. 1964 Dec;11:642–648. doi: 10.1001/archneur.1964.00460240074010. [DOI] [PubMed] [Google Scholar]
  3. KUTT H., WINTERS W., SCHERMAN R., MCDOWELL F. DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE. Arch Neurol. 1964 Dec;11:649–656. doi: 10.1001/archneur.1964.00460240081011. [DOI] [PubMed] [Google Scholar]
  4. Kutt H., McDowell F. Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients. JAMA. 1968 Mar 11;203(11):969–972. [PubMed] [Google Scholar]
  5. Kutt H., Winters W., McDowell F. H. Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy. Neurology. 1966 Jun;16(6):594–602. doi: 10.1212/wnl.16.6.594. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES